Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naloxone for Postictal Respiratory Dysfunction in Epilepsy
NCT02332447Phase 3Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Jun 2015
- Primary completion
- Jul 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of naloxone in epilepsy, sponsored by Hospices Civils de Lyon. Started Jun 2015; status: completed.
02
Drugs
naloxone
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT02332447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02332447.